AwardedPRTGoods
Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
- Published
- Published 1 June 2026
Overview
The Instituto Português de Oncologia do Porto Francisco Gentil procured Dostarlimab 50 mg/ml solution for intravenous injection in 10 ml vials. The contract was awarded to GlaxoSmithKline - Produtos Farmacêuticos, Lda. on 15 May 2026 for €100.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Procedure
- Selective
- Published
- 1 June 2026
Pharmaceutical products
Award outcome
- Awarded value
- €100
- Award date
- 15 May 2026
- GlaxoSmithkline - Produtos Farmacêuticos, Lda.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
1 June 2026
Contracting authority
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Procuring entityPorto, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.